MedTrace Logo

Technical Feasibility of Routine Intraoperative Cholangiography During Elective Rigid-hybrid Transvaginal Natural Orifice Transluminal Endoscopic Cholecystectomy

NCT01583348 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2013-04-30

No results posted yet for this study

Summary

While gold standard in the treatment of symptomatic gall stones is laparoscopic cholecystectomy with instruments introduced through multiple abdominal wall incisions, transvaginal access to the peritoneal cavity offers an alternative avoiding injury of the abdominal wall. Transvaginal hybrid-NOTES cholecystectomy has been demonstrated effective and safe. However it has not been demonstrated up-to-date if intraoperative cholangiography is feasible during such procedure. This observational case series describes success and technical feasibility of intraoperative cholangiography during transvaginal cholecystectomy. The investigators hypothesis is that cholangiography is feasible equal to conventional laparoscopic cholecystectomy.

Conditions

  • Gallstone Disease

Interventions

PROCEDURE

Cholangiography during transvaginal rigid-hybdrid NOTES cholecystectomy

During transvaginal rigid-hybrid NOTES cholecystectomy a intraoperative cholangiography is performed. After dissection of the Calot's triangle and distal clipping of the cystic duct, the cystic duct is incised and a regular cholangiography catheter is inserted. Contrast is injected and an image is obtained using an image-converter. After extraction of the catheter the cystic duct is clipped proximally. This intervention is performed in all patients included in the study.

Sponsors & Collaborators

  • Cantonal Hosptal, Baselland

    lead OTHER

Principal Investigators

  • Andreas Zerz, MD · Cantonal Hospital Baselland, Department of Surgery, Bruderholz, Switzerland

  • Daniel C Steinemann, MD · Cantonal Hospital Baselland, Department of Surgery, Bruderholz, Switzerland

  • Önder Ögredici, MD · Cantonal Hospital Baselland, Department of Surgery, Bruderholz, Switzerland

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2012-10-31
Completion
2013-04-30

Countries

  • Switzerland

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01583348 on ClinicalTrials.gov